1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to

Aarkstore announce a new report "Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 " through its vast collection of market research report.

 
PRLog - Apr. 18, 2012 - GlobalData, Industry analysis specialist, has released its new report, "Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020", an essential and comprehensive source of information and analysis on the global Pulmonary Arterial Hypertension (PAH) therapeutics market. The report identifies and analyzes the key trends shaping and driving the global PAH therapeutics market, as well as treatment usage patterns in the global PAH therapeutics market. The competitive landscape is also covered, with insights into the emerging players expected to significantly alter the positions of the existing market leaders. An in-depth analysis of current pipeline products offers up valuable insights, and the report quantifies the unmet need in the global PAH therapeutics market as well as in the markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China, India and Russia, highlighting opportunities for future players.

This report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData's team of industry experts.

GlobalData estimated the global PAH therapeutics market was worth around $3.3 billion in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 38.6% from 2002 to 2011. PAH is a rare indication but despite the small patient volume, the market showed a tremendous growth in the historic period. This growth was due to the significant drug development activity corresponding to the launch of around eight premium priced drugs in the PAH therapeutics market from 2002 to 2011. Patient volume also increased during this period due to the increasing awareness.

The drugs used in the treatment of PAH are Tracleer (bosentan), Letairis (ambrisentan), Remodulin (treprostinil), Ventavis (iloprost), Revatio (sildenafil), Adcirca (tadalafil), Tyvaso (inhaled treprostinil) and Veletri (epoprostenol). The uptake of these drugs drove the market because of increase in Annual Cost of Therapy (ACOT) of PAH.

The global PAH therapeutics market is estimated to be worth $3.1 billion in 2020. It is forecast to show a negative CAGR of 0.6% from 2011 to 2020.

In 2011, the leading drugs in G7 market (the US, France, Germany, Italy, Spain, the UK and Japan) were Tracleer, Revatio, Letairis/Volibris and Remodulin with sales of $1,303.3m, $439.0m, $364.3m and $363.7m respectively.

For more information, please visit:

http://www.aarkstore.com/reports/Pulmonary-Arterial-Hyper...

Or email us at contact@aarkstore.com or call +918149852585

More reports
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
 Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2011
 Pulmonary Arterial Hypertension - Pipeline Review, H2 2011
 Withdrawal of Sitaxentan (Thelin) Creates Huge Unmet Need in the Pulmonary Arterial Hypertension (PAH) Market
 Pulmonary Arterial Hypertension - Pipeline Review, Q4 2010
 Pulmonary Arterial Hypertension Global Clinical Trials Review, Q4, 2010
 Pulmonary Arterial Hypertension (PAH) - Pipeline Assessment and Market Forecasts to 2016
 Pulmonary Arterial Hypertension (PAH) - Drug Pipeline Analysis and Market Forecasts to 2016
 Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://www.emarketreports.com

Follow us on twitter: http://twitter.com/aarkstoredotcom

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstoreenterprise

http://www.aarkstore.com/feeds/index.xml

http://www.aarkstore.com/feeds/globaldata.xml

# # #

Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.

--- End ---

Click to Share

Contact Email:
***@aarkstore.com Email Verified
Source:Aarkstore Enterprise
Country:India
Industry:Health, Research, Reports
Tags:market forecast, revenues, unmet need, drivers, barriers, pharma, clinical trials, marketed products, pipeline
Shortcut:prlog.org/11852170
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share